Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Aromatase inhibitors, estrogens and musculoskeletal pain: estrogen-dependent T-cell leukemia 1A (TCL1A) gene-mediated regulation of cytokine expression.
Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease.
Incorporating biomarkers into drug labeling.
Anticoagulation in Patients With Atrial Fibrillation in the Setting of Prior Hemorrhage: An Ongoing Dilemma.
Reevaluating the accelerated approval process for oncology drugs.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reevaluating the accelerated approval process for oncology drugs.
Reevaluating the accelerated approval process for oncology drugs. Clin Cancer Res. 2013 Jun 01; 19(11):2804-9.
View in:
PubMed
subject areas
Antineoplastic Agents
Drug Approval
Humans
United States
United States Food and Drug Administration
authors with profiles
Richard Schilsky